Celldex Therapeutics (CLDX) Q3 2021 Earnings

5AugConfirmed
Q3 2020
Q4 2020
Q2 2021
Q3 2021
-0.57
-0.49
-0.42
-0.34

Details

Expected EPS
-0.4
Actual EPS
-0.34
Surprise EPS
0.06
Surprise Percent
+15%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.34 per share for Q3 2021.

0 Comments

Share your thoughts